442 related articles for article (PubMed ID: 11893827)
1. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
[TBL] [Abstract][Full Text] [Related]
2. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
[TBL] [Abstract][Full Text] [Related]
3. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
[TBL] [Abstract][Full Text] [Related]
4. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
[TBL] [Abstract][Full Text] [Related]
5. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A
J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565
[TBL] [Abstract][Full Text] [Related]
7. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
[TBL] [Abstract][Full Text] [Related]
8. [D/D genotype of the gene for angiotensin converting enzyme as a risk factor for post-stent coronary restenosis].
Guarda E; Fajuri A; Marchant E; Martínez A; Jalil J; Illanes G; Vecchiola A; Lazen R; Flores A; Barra V; Irarrázabal S; Ilabaca F
Rev Esp Cardiol; 1999 Jul; 52(7):475-80. PubMed ID: 10439670
[TBL] [Abstract][Full Text] [Related]
9. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting.
Amant C; Bauters C; Bodart JC; Lablanche JM; Grollier G; Danchin N; Hamon M; Richard F; Helbecque N; McFadden EP; Amouyel P; Bertrand ME
Circulation; 1997 Jul; 96(1):56-60. PubMed ID: 9236417
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
[TBL] [Abstract][Full Text] [Related]
11. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.
Osadnik T; Strzelczyk JK; Fronczek M; Bujak K; Reguła R; Gonera M; Gawlita M; Kurek A; Wasilewski J; Lekston A; Gierlotka M; Hawranek M; Ostrowska Z; Wiczkowski A; Poloński L; Gąsior M
Adv Med Sci; 2016 Sep; 61(2):276-281. PubMed ID: 27162064
[TBL] [Abstract][Full Text] [Related]
13. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients.
Taniguchi I; Yamazaki T; Wagatsuma K; Kurusu T; Shimazu Y; Takikawa K; Yoshikawa M; Kageyama S; Mochizuki S
Jpn Circ J; 2001 Oct; 65(10):897-900. PubMed ID: 11665795
[TBL] [Abstract][Full Text] [Related]
14. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation.
Canosi U; Angelica Merlini P; Bernardi F; Repetto A; Bramucci E; Ferrario M; Angoli L; Gnecchi M; Ferraresi P; Marchetti G; Tavazzi L; Ardissino D
Thromb Haemost; 2004 Apr; 91(4):795-800. PubMed ID: 15045142
[TBL] [Abstract][Full Text] [Related]
16. ACE gene polymorphism and coronary restenosis.
Bauters C; Amouyel P; Bertrand ME
Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.
Ribichini F; Wijns W; Ferrero V; Matullo G; Camilla T; Feola M; Guarrera S; Vado A; Piazza A; Uslenghi E
Am J Cardiol; 2003 Jan; 91(2):154-8. PubMed ID: 12521626
[TBL] [Abstract][Full Text] [Related]
18. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
Bauters C; Amouyel P
Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
[TBL] [Abstract][Full Text] [Related]
20. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
